 |
Guidelines for the Prevention Of Medication Errors
The prevention of medication errors
is an essential requirement for
pharmaceutical care and must be a
core mission of every pharmacy. If efforts
to prevent medication errors are to be
effective and successful, they must
become a priority.
MARCH, 2009 |
 |
Current Concepts in the Prevention of Venous Thromboembolism
Venous thromboembolism
(VTE), comprised of deep vein
thrombosis (DVT) and pulmonary
embolism (PE), is a major cause of death,
disability, and economic burden worldwide.
VTE afflicts millions of individuals and
accounts for several hundred thousand
deaths annually in the United States.
FEBRUARY, 2009 |
 |
Immune Globulins: Therapeutic, Pharmaceutical, Cost, and Administration Considerations
For all of the immune globulin (Ig) products produced in the United
States, there are only 5 FDA-approved indications. The most
recent approval was in September 2008 for chronic inflammatory
demyelinating polyneuropathy (CIDP) for Gamunex (Talecris).
JANUARY, 2009 |
 |
Carbapenem Antibiotics: Maximizing Response and Minimizing Resistance
ROBERT P. RAPP, PHARMD, FCCP
CRAIG MARTIN, PHARMD
OCTOBER, 2008 |
 |
Chemotherapy-Induced Nausea and Vomiting: Treatment Guidelines
DAVID G. FRAME, PHARMD
WILLIAM LESLIE, MD
OCTOBER, 2008 |
 |
Guidelines for the Prevention Of Medication Errors
INSTITUTE FOR SAFE MEDICATION PRACTICES
OCTOBER, 2008 |
 |
Breast Cancer Management: Updates in Adjuvant Chemotherapy For Early-Stage Disease
With an estimated 182,460 new cases and 40,480 related
deaths in 2008, breast cancer remains the most common
malignancy among US women and the second most lethal.
During the 1980s, annual increases in the rate of breast cancer of
approximately 3.7% were largely attributed to the widespread
adoption of screening mammography.
OCTOBER, 2008 |
 |
The Medical Treatment of Metastatic Colorectal Cancer
Colorectal cancer is the third leading cause of cancer
deaths in men and women in the United States, with
an estimated total of 49,960 deaths in 2008. The high
number of deaths can be attributed to the inability to achieve
cures in a substantial number of patients with metastatic disease.
AUGUST, 2008 |
|